tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
GMAB
Genmab
RESEARCH TOOLSreports
Advertisement

Genmab (GMAB) Stock News & Sentiment

Compare
710 Followers
Promising Clinical Developments in Genmab’s Portfolio Reinforce Buy Rating
Premium
Ratings
Promising Clinical Developments in Genmab’s Portfolio Reinforce Buy Rating
4d ago
GMAB
Genmab’s Oncology Advancements and Strategic Positioning Drive Buy Rating
Premium
Ratings
Genmab’s Oncology Advancements and Strategic Positioning Drive Buy Rating
5d ago
GMAB
Genmab Reports Strong Q3 2025 DARZALEX® Sales
Premium
Company Announcements
Genmab Reports Strong Q3 2025 DARZALEX® Sales
8d ago
6K
GMAB
Genmab’s Strong Market Position and Growth Potential Justify Buy Rating with $40 Price Target
Premium
Ratings
Genmab’s Strong Market Position and Growth Potential Justify Buy Rating with $40 Price Target
10d ago
GMAB
Sell Rating on Genmab A/S: Strategic Moves and Financial Challenges Ahead
Premium
Ratings
Sell Rating on Genmab A/S: Strategic Moves and Financial Challenges Ahead
15d ago
GMAB
Genmab A/S Updates Articles of Association to Enhance Growth Strategy
Premium
Company Announcements
Genmab A/S Updates Articles of Association to Enhance Growth Strategy
25d ago
6K
GMAB
Genmab’s Strategic Acquisitions and Promising Pipeline Drive Buy Rating
Premium
Ratings
Genmab’s Strategic Acquisitions and Promising Pipeline Drive Buy Rating
26d ago
GMAB
More GMAB News >

GMAB News on the Web

Truist Financial Remains a Buy on Genmab (GMAB)
TipRanks News
Neutral
Genmab's Rina-S Shows 50% Response Rate in Tough-to-Treat Endometrial Cancer—Phase 3 Trial Underway After FDA Breakthrough Designation
Market Chameleon
Neutral
Why Genmab A/S’s (GMAB) Stock Is Down 6.39%
AAII
Neutral
Genmab's Rina-S Achieves 50% Response Rate In Advanced Endometrial Cancer Trial
rttnews
Neutral
GMAB or TECH: Which Is the Better Value Stock Right Now?
Zacks
Neutral
Leerink Partners Reaffirms Their Buy Rating on Genmab (GMAB)
TipRanks News
Neutral
4 biotech bargains with realistic upside
Live Wire
Neutral
GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal
Zacks
Neutral

News Score - Last 7 Days

Neutral
GMAB
Sector Average
Media Buzz
This Week5 articles
Weekly Average4.25 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GMAB’s Media Buzz Sentiment?
5 articles about GMAB were published this week. In an average week, 4.25 articles are published.
    What is GMAB’s weekly average amount of articles?
    In an average week, 4.25 articles about GMAB are published.
      What is GMAB’s News Sentiment?
      50% of articles about GMAB were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        NNVCNanoViricides
        ALKSAlkermes
        EHCEncompass Health
        NBIXNeurocrine
        VSTMVerastem
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing